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Title: Transforming children and young people’s mental health 
provision: a green paper 
IA No:       14001 
RPC Reference No: N/A         
Lead department or agency:   Department of Health        
Other departments or agencies:   Department for Education 
 
Impact Assessment (IA) 
Date: 04/12/2017 
Stage: Consultation 
Source of intervention: Domestic 
Type of measure: Other 
Contact for enquiries: 
youngmentalhealth@dh.gsi.gov.uk 
 
 
 
 
 
 
Summary: Intervention and Options  
 
RPC Opinion: Not Applicable 
 Cost of Preferred (or more likely) Option 
Total Net 
Present Value 
Business Net 
Present Value 
Net cost to business per 
year (EANDCB in 2014 prices) 
One-In,  
Three-Out 
Business Impact Target 
Status 
 
£2,629m £0m £0m Not in scope Not a regulatory provision 
What is the problem under consideration? Why is government intervention necessary? 
There is a need to increase support to children and young people (CYP) with mild to moderate mental health conditions in 
England, and to reduce the length of time that those who need specialist NHS Children and Young People’s (CYP) mental health 
services wait for treatment. 
 
 
What are the policy objectives and the intended effects? 
To increase support to children and young people (CYP) with mild to moderate mental health conditions in England, and to reduce 
the length of time that those who need specialist NHS Children and Young People’s (CYP) mental health services wait for 
treatment.  
The intended effects are a) improved quality of life for CYP living with a mental health condition b) improved outcomes for CYP 
living with a mental health condition c) reduced overall severity and impact of mental health conditions and thereby improved 
future earnings/ productivity,  reduced burden on the health and social care system, education system and the criminal justice 
system. 
 
What policy options have been considered, including any alternatives to regulation? Please justify preferred 
option (further details in Evidence Base) 
Option 1: Do nothing. 
Option 2: Incentivise and support all schools and colleges to identify a Designated Senior Lead for Mental Health.   
Option 3: Option 2 plus new Mental Health Support Teams working with schools to provide support for those with mild to 
moderate needs. Without Option 2, Mental Health Support Teams would not be jointly managed by Designated Senior Leads for 
Mental Health and would not have a crucial link into schools and colleges. 
Option 4: Option 3 plus a series of CYP Mental Health Services (CYPMHS) waiting time pilots. Without investing in prevention and 
early intervention for mild to moderate mental health problems provided by Option 3, demand for CYPMHS services could 
continue rising making it difficult  to deliver a waiting time standard. 
 
Option 4 is the preferred option. 
 
Will the policy be reviewed?  It will be reviewed.  If applicable, set review date:  Ongoing review 
Does implementation go beyond minimum EU requirements?  Yes 
Are any of these organisations in scope? Micro No 
Small 
No 
Medium 
No 
Large 
No 
What is the CO2 equivalent change in greenhouse gas emissions?  
(Million tonnes CO2 equivalent)   
Traded:    
N/A 
Non-traded:    
N/A 
I have read the Impact Assessment and I am satisfied that, given the available evidence, it represents a 
reasonable view of the likely costs, benefits and impact of the leading options. 
 
Signed by the responsible Director: Chris Mullin, Department of Health Chief Economist   
Date: 4th Dec 2017 
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Summary: Analysis & Evidence Policy Option 1 
Description:  Do nothing 
FULL ECONOMIC ASSESSMENT 
Price Base 
Year       
PV Base 
Year       
Time Period 
Years       
Net Benefit (Present Value (PV)) (£m) 
Low:  High:  Best Estimate:       
 
COSTS (£m) Total Transition  
 (Constant Price) Years 
 
 
Average Annual  
(excl. Transition) (Constant Price) 
Total Cost  
(Present Value) 
Low   
    
  
High     
Best Estimate 
 
0 0      0      
Description and scale of key monetised costs by ‘main affected groups’  
N/A  
Other key non-monetised costs by ‘main affected groups’  
Without intervention, there will continue to be a need to increase support for CYP with mental health illnesses and lower level 
needs. This will continue imposing costs on schools, carers, and CYPMHS and wider services such as criminal justice and social care. 
BENEFITS (£m) Total Transition  
 (Constant Price) Years 
 
 
Average Annual  
(excl. Transition) (Constant Price) 
Total Benefit  
(Present Value) 
Low   
    
  
High     
Best Estimate 
 
0      0      0      
Description and scale of key monetised benefits by ‘main affected groups’  
N/A 
Other key non-monetised benefits by ‘main affected groups’  
N/A 
Key assumptions/sensitivities/risks Discount rate (%) 
 
N/A 
We have assumed that in the ‘do nothing’ scenario, prevalence of CYP with diagnosable mental health disorders will remain at the 
last recorded level (measured in 2004), due to an absence of robust population level evidence. However, there is indicative 
evidence that prevalence of mental health problems among CYP may be increasing. 
 
BUSINESS ASSESSMENT (Option 1) 
Direct impact on business (Equivalent Annual) £m:  Score for Business Impact Target (qualifying 
provisions only) £m: 
Costs: 0 Benefits: 0 Net:      0 
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Summary: Analysis & Evidence Policy Option 2 
Description:  Incentivise and support all schools and colleges to identify a Designated Senior Lead for Mental Health. 
FULL ECONOMIC ASSESSMENT 
Price Base Year 
2016/17     
PV Base Year  
    2017/18 
Time Period Years  
    5 Net Benefit (Present Value (PV)) (£m) 
Low: -94 High: -71 Best Estimate: -83 
 
COSTS (£m) Total Transition  
 (Constant Price) Years 
 
 
Average Annual  
(excl. Transition) (Constant Price) 
Total Cost  
(Present Value) 
Low   
0 
 71 
High    94 
Best Estimate 
 
  83 
Description and scale of key monetised costs by ‘main affected groups’  
The cost associated with incentivising and supporting Designated Senior Leads for Mental Health in schools and colleges will 
be national roll-out of school/college – CYPMHS joint training (assumed £7.6m over five years), plus one-off funding for 
training to schools and colleges with Designated Senior Leads . This will cover the costs of a significant training programme 
and provide up to £15-20m each year from 2019 to cover costs until all schools and colleges have had the opportunity to 
train a Lead (assumed five years for modelling purposes). 
  
Other key non-monetised costs by ‘main affected groups’ 
There is an opportunity cost of the time teachers or other school/college staff (acting as Designated Senior Lead) spend on training 
and delivering the Lead role. However it is not possible to robustly estimate this. We have assumed that any extra workload burden 
on CYMPHS will be absorbed by the expansion set out in Mental Health Support teams and therefore have not included costs to 
CYMPHS.  However, if this was the only element of new support to improve CYPMHS we would anticipate a further cost to CYPMH 
to provide appropriate liaison, for this reason this option is not recommended as a standalone option.    
BENEFITS (£m) Total Transition  
 (Constant Price) Years 
 
 
Average Annual  
(excl. Transition) (Constant Price) 
Total Benefit  
(Present Value) 
Low   
1    
  
High     
Best Estimate 
 
            Unquantified      
Description and scale of key monetised benefits by ‘main affected groups’  
None 
Other key non-monetised benefits by ‘main affected groups’  
Increase in quality of working relationships between schools/colleges and CYPMHS. Improvements in Designated Senior Leads for 
Mental Health’s understanding of referral pathways, leading to an increase in appropriate referrals resulting in treatment and 
decreased referrals of CYP who do not meet the threshold for specialist treatment. Some increased availability of mental health 
support within schools. Improved knowledge and understanding of mental health issues among wider school staff, supporting 
improved early identification and support. 
Key assumptions/sensitivities/risks Discount rate (%) 
 
3.5 
There is a risk that in the short term the demand for CYPMHS treatment rises if there is an increase in the number of CYP with 
severe needs who are identified as needing CYPMHS treatment, through the implementation of the Mental Health Support Teams 
and Designated Senior Leads in schools and colleges. There is also a risk that the training offer does not incentivise schools and 
colleges to designate Leads, or that even with Leads they do not take up the training offer. 
 
BUSINESS ASSESSMENT (Option 2) 
Direct impact on business (Equivalent Annual) £m:  Score for Business Impact Target (qualifying 
provisions only) £m: 
Costs: 0 Benefits: 0 Net:      0 
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Summary: Analysis & Evidence Policy Option 3 
Description:  Option 2 plus creation of new Mental Health Support Teams to provide support for those with mild to 
moderate mental health needs. 
FULL ECONOMIC ASSESSMENT 
Price Base Year  
2016/17     
PV Base Year  
    2017/18 
Time Period Years  
10 Net Benefit (Present Value (PV)) (£m) 
Low: 1,642 High: 6,371 Best Estimate: 2,674 
 
COSTS (£m) Total Transition  
 (Constant Price) Years 
 
 
Average Annual  
(excl. Transition) (Constant Price) 
Total Cost  
(Present Value) 
Low   
9 
  
High     
Best Estimate 
 
            1,265 
Description and scale of key monetised costs by ‘main affected groups’  
Designated Senior Lead for Mental Health in schools and colleges,as in Option 2.  
New Mental Health Support Teams to work with schools and colleges and support CYP with mild to moderate mental 
health needs, providing a link with CYPMHS - £255m discounted annual financial cost as at full implementation, includes 
costs to train and employ the new workforce of approx. 8,000 FTE, equivalent to £255m economic cost. 
 
 
 
Other key non-monetised costs by ‘main affected groups’ 
In addition to the non-monetised costs set out for Option 2 there is an opportunity cost to CYP of the time spent participating in 
mental health interventions, time otherwise spent on learning or other activities (partially offset by reduced absenteeism). 
However it is not possibly to robustly estimate this.  
 
 
BENEFITS (£m) Total Transition  
 (Constant Price) Years 
 
 
Average Annual  
(excl. Transition) (Constant Price) 
Total Benefit  
(Present Value) 
Low   
9 
 2,907 
High    7,636 
Best Estimate 
 
       3,939 
Description and scale of key monetised benefits by ‘main affected groups’  
New Mental Health Support Teams - £3,939m discounted benefit (NHS savings and productivity benefit). 
Other key non-monetised benefits by ‘main affected groups’  
Reduction in mental ill health of children (continuing into adulthood), resulting in improvements in quality of life. Fewer referrals 
to CYPMHS of children who do not meet the threshold for specialist treatment, reducing administrative burden. Increased 
proportion of referrals to CYPMHS which result in treatment. Savings/increased revenue to other government departments 
(OGDs) (Ministry of Justice, Home Office, Department for Work and Pensions (DWP), HMRC) due to reduced  costs to the criminal 
justice system and increased productivity. Social care savings may accrue to individuals and Local Authorities. Savings to 
Department for Education/education system e.g. through, decreased costs of addressing truancy and exclusions. Decreased risk of 
physical health problems.  
 
 
Key assumptions/sensitivities/risks Discount rate (%) 
 
3.5   
   We have assumed that 60% of children with a diagnosable mental health condition who are not currently referred to CYPMHS 
would benefit from some form of specialist treatment, and that 60% of those would receive specialist support from the new 
Mental Health Support Teams. We have also assumed that half of the CYP receiving a CYPMHS assessment, but who do not meet 
the threshold for CYPMHS treatment, would instead receive specialist support through the teams. There is a lack of evidence 
around the number of CYP who have low level mental health needs (but do not have a diagnosable mental health disorder) who 
currently would not be referred to CYPMHS but would likely be supported by the Mental Health Support Teams. 
 
There is a risk that in the short term the demand for CYPMHS treatment rises if there is an increase in the number of children with 
severe needs who are identified as needing CYPMHS treatment, through the implementation of the Mental Health Support Teams 
and Designated Senior Leads in schools and colleges. There is high uncertainty in the estimated benefits, as these will depend on 
the details of policy implementation, which is currently in the process of consultation and will be tested via Trailblazers in the first 
phases of roll out. 
 
 
BUSINESS ASSESSMENT (Option 3) 
Direct impact on business (Equivalent Annual) £m:  Score for Business Impact Target (qualifying 
provisions only) £m: 
Costs: 0 Benefits: 0 Net: 0 
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Summary: Analysis & Evidence Policy Option 4 
Description:  Option 3 plus CYPMHS waiting time pilots. 
FULL ECONOMIC ASSESSMENT 
Price Base 
Year  
2016/17 
PV Base Year  
2017/18  
   
Time Period 
Years  10     
Net Benefit (Present Value (PV)) (£m) 
Low: 1,597 High: 6,326 Best Estimate: 2,629 
 
COSTS (£m) Total Transition  
 (Constant Price) Years 
 
 
Average Annual  
(excl. Transition) (Constant Price) 
Total Cost  
(Present Value) 
Low   
9    
  
High     
Best Estimate 
 
 •            1,310 
Description and scale of key monetised costs by ‘main affected groups’  
Equivalent to the costs of Option 3, plus an amount of money for piloting new service delivery models for achieving reduced waits. 
This fund will include an allowance for robust evaluation of the pilots. For the purpose of this analysis, we assign a total cost of c. 
£50m. 
 
  
Other key non-monetised costs by ‘main affected groups’ 
These are equivalent to those of Option 3. 
BENEFITS (£m) Total Transition  
 (Constant Price) Years 
 
 
Average Annual  
(excl. Transition) (Constant Price) 
Total Benefit  
(Present Value) 
Low   
9 
 2,907 
High    7,636 
Best Estimate 
 
            3,939 
Description and scale of key monetised benefits by ‘main affected groups’  
New Mental Health Support Teams - £3,939m discounted financial benefit (NHS savings and productivity benefit). 
Other key non-monetised benefits by ‘main affected groups’  
Equivalent to non-monetised benefits for Option 3. In addition: CYPMHS waiting times pilot – reduction in anxiety and distress of 
CYP and family while waiting for treatment, quality of life benefit from reduced proportion of life lived with pre-treatment quality 
of life. Break-even analysis suggests that the benefits of waiting times pilots are likely to outweigh their costs. 
Key assumptions/sensitivities/risks Discount rate (%) 
 
3.5 
Equivalent to key assumptions/sensitivities/risks as Option 3.  
 
BUSINESS ASSESSMENT (Option 4) 
Direct impact on business (Equivalent Annual) £m:  Score for Business Impact Target (qualifying 
provisions only) £m: 
Costs: 0 Benefits: 0 Net: 0 
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This is a supporting document to analyse the proposals within “Transforming children and young people’s mental 
health provision: a green paper1.” Herein referred to as the Green Paper.  
1. Evidence Base 
Problem under consideration;  
There is a need to increase support to children and young people (CYP) with mild to moderate mental health 
conditions in England, and to reduce the length of time that those who need specialist NHS CYP mental health 
services wait for treatment. 
Children and young people (CYP) can experience mental health needs in different ways, and receive or need 
different types of support for these needs. There are broadly three groups of CYP to consider: 
• CYP who are pre-diagnosable, have mild or low-level needs which do not constitute a diagnosable mental 
health condition but are at risk of developing one and would benefit from a form of support; 
• Those who have a diagnosable mental health condition with mild to moderate needs that do not meet 
thresholds for specialist NHS Children and Young People Mental Health Services (CYPMHS) treatment; 
• CYP with diagnosable conditions (with often but not exclusively, severe needs) that meet thresholds for 
CYPMHS treatments. 
Mental health problems affect a large number of CYP at any one time. Our most recent data (from 2004) indicates 
that around 10% of CYP will have a diagnosable mental health disorder at any one time.2 This is equivalent to 
around 850,000 CYP between the ages of 5 and 18. Note that prevalence may have risen since 2004 and data is 
not collected on the number of children who have pre-diagnosable, lower level needs.  
The NHS provides mental health care for CYP experiencing serious problems. There are currently around 460,000 
referrals to CYP’s NHS-funded  mental health services a year, with 200,000 going on to receive treatment in NHS-
funded services and many being appropriately signposted to other help. The government is committed to 
improving access to CYP mental health support and has committed to deliver 70,000 additional treatments in 
2020/21 compared to 2014/15. 
Waits for treatment can vary considerably in different areas, with the shortest around four weeks and the longest 
in one provider with waits of up to 100 weeks from referral to treatment. Latest data shows that in 2016/17 the 
average wait for treatment in a CYPMHS was 12 weeks3. 
Provision for those with mild / moderate mental health needs is variable. Support is provided via a number of 
routes, including: NHS services, schools, and local authorities (LAs) and other services.  
We know that the majority of schools offer some form of mental health provision across a range of types of 
activities from universal prevention and promotion activities to providing targeted support for those with mild to 
moderate needs, such as school based counselling.4 However, schools report difficulty finding funding for mental 
health provision and also that they struggle to know what services, programmes or activities would be best to 
                                            
1 Department of Health (2017). Transforming children and young people’s mental health services: a green paper. Available at: www.gov.uk 
2 Green, et al. (2005). Mental health of children and young people in Great Britain, 2004. Basingstoke: Palgrave MacMillan. Available at:  
http://digital.nhs.uk/catalogue/PUB06116   
3 Time from referral to the second contact. Digital.nhs.uk. 2017.  http://content.digital.nhs.uk/media/25613/NHS-England-CYPMH-Additional-
Waiting-Time-Statistics-FINAL/xls/NHS_England_CYPMH_Additional_Waiting_Time_Statistics_FINAL.xlsx  (accessed November 2017) 
4 Marshall, et al. (2017). Supporting Mental Health in Schools and Colleges: Quantitative Survey. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/634726/Supporting_Mental-Health_survey_report.pdf 
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invest in.5 We know that LAs and other services can and do provide mental health support (e.g. School Nurses, 
educational psychologists, Youth Information Advice and Counselling Services), but we do not have good evidence 
of exactly what is provided.  
There is also a need to improve join up between NHS and schools. The evaluation of the Mental Health Services 
and Schools Link Pilot found that, prior to the pilot, areas experienced a range of difficulties in joint working 
between schools and NHS CYPMHS. These include misunderstanding of referral routes, schools not being able to 
refer directly into NHS CYPMHS, poor communication and a lack of ability to share data and outcomes relating to 
referrals. While the pilot areas are not necessarily representative of the wider country, they did suggest a range of 
different starting points for joint working. 
2. Rationale for intervention;  
Intervention improves quality of life for the individual and improved outcomes generate benefits for society. 
There is evidence that intervention in childhood is more cost-effective than intervention at a later stage. 
Short and long term effects of CYP mental health problems 
As shown above, mental health problems affect a large number of CYP. Problems that begin in childhood and 
adolescence can lead to significant distress, with a range of negative impacts on individuals and families, and 
these can continue into adult life unless properly treated. The Chief Medical Officer has highlighted that without 
CYP’s mental health services there is a wider cost to society, while effective early treatment can help improve 
individual’s attainment and relationships later in life.6 
The evidence suggests that CYP with mental health problems often experience issues in many areas of their life: 
• CYP with mental health problems are more likely to experience increased disruption to their 
education, via time off school and exclusions, than children with no mental health problems. 7 8 CYP 
with mental health disorders are 18 times more likely to be excluded from school than those 
without.9 A quarter of CYP with mental health problems report not going into school due to concerns 
about what others think about their mental health problems.10 
• CYP with diagnosable mental health problems are more likely to be assessed as being behind in their 
schooling, with 9% being assessed as being two or more years behind.11 
• Young people with mental health problems are more likely to experience problems in their future 
employment, with various longitudinal studies suggesting a long-term impact on economic activity 
such as receipt of welfare benefits, income, and continuous employment. 12 13 14 
                                            
5 White, et al. (2017). Supporting Mental Health in Schools and Colleges: Qualitative case studies. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/634728/Supporting_Mental-health_Case_study_report.pdf 
6Murphy, & Fonagy (2012). Annual Report of the Chief Medical Officer 2012, Our Children Deserve Better: Prevention Pays. Chapter 10. 
Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/252660/33571_2901304_CMO_Chapter_10.pdf  
7 Although caution should be taken due to small numbers of CYP excluded. 
8 Representative sample of 5-16 year olds. Includes conduct disorder, emotional disorders, hyperkinetic disorders, less common disorders (e.g. 
autism spectrum disorder, tic disorder, eating disorders). Proportion of children experiencing time off school: 17% emotional disorders, 14% with 
conduct disorders, 11% with hyperkinetic disorders, 5% children with no disorder – away from school for over 15 days in the previous term.  
Green, et al. (2005). Mental health of children and young people in Great Britain, 2004. Basingstoke: Palgrave MacMillan. Available at: 
http://digital.nhs.uk/catalogue/PUB06116 
9 Meltzer, et al. (2003). Persistence, onset, risk factors and outcomes of childhood mental disorders. Available at: 
http://webarchive.nationalarchives.gov.uk/+/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsStatistics/DH_4081089 
10 Time to Change (2014). Students missing out on education because of mental illness. Available at: https://www.time-to-
change.org.uk/news/students-missing-out-education-because-mental-illness 
11 PQ 207563, 5 September 2014. Available at: http://www.parliament.uk/business/publications/written-questions-answers-statements/written-
question/Commons/2014-09-01/207563/ 
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• One quarter of boys in Youth Offender Institutions reported emotional or mental health problems.15 
• Over two fifths of CYP on community orders had emotional and mental health needs.16 
• Young people with conduct disorder are more likely to engage in criminal activity, with research 
suggesting they are 20 times more likely to end up in prison, and four times more likely to become 
dependent on drugs, compared to the general population.17 
When difficulties start below secondary school age, they have particularly long lasting effects on children’s 
prospects, with around half of children with conduct disorder going on to have very poor life chances including an 
increased risk of a wide range of adult mental illnesses.18  For example, compared with their peers, children aged 
7-9 with conduct disorder are on average19: 
• Twice as likely to leave school with no qualifications; 
• Four times more likely to become drug dependent; 
• Six times more likely to die before the age of 30; 
• Eight times more likely to be placed on a child protection register; 
• 20 times more likely to end up in prison 
15-20% of children have behavioural difficulties falling short of a diagnostic threshold but which nevertheless 
carry increased risk of poorer outcomes in later life. 
In addition to childhood issues caused by mental health problems, there is good evidence that adult mental 
health problems begin in childhood or adolescence: 
• A British cohort study showed that teens who had common mental disorders (CMDs)20 were more than 
two and a half times more likely to have a common mental disorder at age 36, compared with mentally 
healthy teenagers (although by the age of 53 there was no difference). For teens with persistent CMD 
(CMD at age 13 and 15), they were over six times more likely to have CMD at age 36 and 43, and four 
times more likely at age 53 (although there were less than 50 people in this group).21 
                                                                                                                                                         
12 Knapp, et al. (2016). Youth Mental Health: New Economic Evidence. Available at: http://www.pssru.ac.uk/archive/pdf/5160.pdf - Analysis of 
APMS data, 16-25 year olds, 27% vs 16%.  
13 Childhood mental health and life chances in post-war Britain: Insights from three national birth cohort studies (2009). Available at: 
http://www.rcpsych.ac.uk/pdf/life_chances_summary%20(2).pdf  
14 Goodman, et al. (2011). The long shadow cast by childhood physical and mental problems on adult life. Available at: 
http://www.pnas.org/content/108/15/6032.full.pdf  
15 HMIP (2016). Children in Custody 2015-16: An analysis of 12-18 year olds’ perceptions of their experiences in secure training centres and 
young offender institutions. Available at: https://www.justiceinspectorates.gov.uk/hmiprisons/wp-content/uploads/sites/4/2016/11/Children-in-
Custody-2015-16_WEB.pdf 
16 Healthcare Commission (2009). Actions speak louder: A second review of healthcare in the community for young people who offend. 
Available at: http://www.ohrn.nhs.uk/resource/policy/Actionsspeaklouder.pdf 
17 Parsonage, et al. (2014). Building a better future: the lifetime costs of childhood behavioural problems and the benefits of early intervention. 
Centre for Mental Health. Available at: 
https://www.researchgate.net/publication/308085041_Building_a_better_future_the_lifetime_costs_of_childhood_behavioural_problems_and_th
e_benefits_of_early_intervention  
18 Moffitt (2006). Life-course-persistent versus adolescence-limited antisocial behaviour: a 10-year research review and a research agenda.  
In: Cicchetti, & Cohen [Eds.]. Risk, Disorder, and Adaptation, Developmental Psychopathology, 3, 720-98. Hoboken, NJ: John Wiley. 
19 Fergusson, et al. (2005). Show me a child at seven: consequences of conduct problems in childhood for psychosocial functioning in 
adulthood. Journal of Child Psychology and Psychiatry, 46, 837 - 849. Available at: https://www.ncbi.nlm.nih.gov/pubmed/16033632 
20 Teens were rated by their teachers at age 13 and 15, on items similar to those seen in internalising disorders such as depression and anxiety. 
Survey participants scoring in the top 6% of the population distribution were defined as cases of ‘common mental disorder’ (CMD) (n=277 at 
either age). Those who met the definition at both 13 and 15 years were defined as ‘persistent CMD’ (n=46). 
21 Jones (2013). Adult mental health disorders and their age at onset. The British Journal of Psychiatry, 202 , s5-s10. Available at: 
http://bjp.rcpsych.org/content/202/s54/s5 
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• Longitudinal research from New Zealand shows that half of 26 year old adults with a diagnosable mental 
health problem also had symptoms before age 15, and seventy-five per cent before age 18.22 
• A study from the US showed that half of lifetime cases of mental illness start by age 14 and seventy-five 
per cent by age 24.23   
Adults with mental health problems are much more likely to have other disadvantages, including: 
• Lower incomes in early adulthood and into middle age.24 
• Lower probability of being in work in middle age.25 
• Increased risk of problems with their physical health, including cardiovascular disease, gum disease, 
serious injury, nicotine dependency, and increased risk of hospitalisation in males. 26 27 
• Increased involvement in the criminal justice system – both as victims and perpetrators. For example, 
people with severe mental health problems are more likely to be a victim of violent crime than the 
general population.28 Similarly, compared to the general population, prisoners in the UK are more likely to 
have a mental illness, including psychosis, personality disorder, depression and anxiety.29 
Child and adolescent mental health problems are costly, with the annual short-term costs estimated at £1.58 
billion and the annual long-term costs estimated at £2.35 billion.30 The wide range of associated adverse 
outcomes means that the costs affects a wide range of services including education, social care, youth and 
criminal justice, adult health, and welfare. As just one example, the total annual social care costs for mental 
disorder across CYP aged 5-15 in England are calculated at £67 million.31 
Early intervention and quick access to good quality care is vital, especially for CYP. Mental health specialists 
encourage earlier and more intensive therapy to help increase the likelihood of achieving recovery and therefore 
lead to a lower overall cost of care.32 
There is evidence that waiting times influence engagement with treatment. In the US, a longer waiting time has 
been associated with refusal to engage with treatment when offered, taking into account symptom severity.33 In 
Switzerland, waiting time for the first appointment has also been found to be a significant predictor of a patient’s 
‘alliance’ with their therapist.34   
                                            
22 Kim-Cohen, et al (2003). Prior juvenile diagnoses in adults with mental disorder: Developmental follow-back of a prospective-longitudinal 
cohort. Archive of General Psychiatry, 60(7), 709-717. Available at: http://jamanetwork.com/journals/jamapsychiatry/fullarticle/207619 
23 Kessler, et al. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. 
Archives of General Psychiatry, 62(6), 593-60. 
24 Goodman, et al. (2011). The long shadow cast by childhood physical and mental problems on adult life. Proceedings of the National Academy 
of Sciences, 108(15), 6032–6037.  Available at: http://www.pnas.org/content/108/15/6032.full  
25 ibid 
26 Odgers, et al. (2007). Prediction of differential adult health burden by conduct problem subtypes in males. Arch Gen Psychiatry, 64(4),476-
484. Available at: http://jamanetwork.com/journals/jamapsychiatry/fullarticle/210006 
27 Goodman, et al. (2011). The long shadow cast by childhood physical and mental problems on adult life. Proceedings of the National Academy 
of Sciences, 108(15), 6032–6037. Available at: http://www.pnas.org/content/108/15/6032.full 
28 Teplin, et al. (2005). Crime victimization in adults with severe mental illness. Arch Gen Psychiatry, 62(8), 911-921. 
29 Mental Health and Criminal Justice. Views from consultation across England & Wales (2016). Centre for Mental Health. Available at: 
https://www.centreformentalhealth.org.uk/Handlers/Download.ashx?IDMF=83a8bfa6-678f-470e-9f49-de5c0769e752 
30 Strelitz (2012). The economic case for a shift to prevention. Annual Report of the Chief Medical Officer 2012 – Our Children Deserve Better: 
Prevention Pays. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/252653/33571_2901304_CMO_Chapter_3.pdf   
31 ibid   
32 Halfin (2007). Depression: The benefits of early and appropriate treatment. AJMC. Available at: 
http://www.ajmc.com/journals/supplement/2007/2007-11-vol13-n4suppl/nov07-2638ps092-s097.. 
33 Sherman, et al. (2009). Clinical intake of child and adolescent consumers in a rural community mental health center: does wait-time predict 
attendance? Community Mental Health Journal, 45(1), 78-84. Available at: https://www.ncbi.nlm.nih.gov/pubmed/18807182. 
34 Kapp, et al. (2017). Identifying the determinants of perceived quality in outpatient child and adolescent mental health services from the 
perspectives of parents and patients. European Child and Adolescent Psychiatry,26(10),1269-1277. Available at: 
https://www.ncbi.nlm.nih.gov/pubmed/28382545 
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Mental health support for CYP outside of specialist services 
Future in Mind35 clearly set out the evidence for the role of schools and colleges in the promotion of good mental 
health, identification of needs and as a location for the provision of initial support. Moreover, we know that many 
schools and colleges acknowledge this role and are keen to act on it.36 Furthermore, CYP themselves value school-
based mental health support and consider school-based counselling helpful.37 
The evidence review38 commissioned to inform the Green Paper reports a number of ways in which schools are 
well-placed to support children with mental health issues:  
• The school setting offers many opportunities for identifying CYP at risk. School staff may be particularly 
well placed to spot behaviours and risk factors to support the early identification of specific mental health 
problems (such as eating disorders and self-harm); 39 
• The school environment is well suited to a graduated approach to children’s mental health, where 
children at risk can be identified and a range of interventions (including prevention) can be offered to 
address problems; 
• As the school environment can present triggers for many difficulties (such as social anxiety, test anxiety, 
peer influences in some conditions), there is a strong case for locating support in the school to help 
manage these challenges; 
• The school environment is non-stigmatizing and accessible, making interventions offered in this context 
more acceptable to CYP, and their parents; 
• There is evidence to show that staff without a mental health background, including teachers, can be 
trained to deliver some specific interventions, with outcomes comparable to mental health professionals. 
We also know that there are interventions available for children that appear to have positive impacts on mental 
health/behaviour, and wider impacts on schooling, parental relationships, etc. For example: 
• For conduct disorder, there are a range of interventions that can have positive outcomes, such as group 
and individual parenting programmes, school-based programmes, and functional family therapy.40 
• For emotional disorders such as anxiety and depression, group cognitive behavioural therapy (CBT) in a 
school setting has been shown to reduce depressive symptoms, and symptoms of anxiety.41  
• There are a range of other types of interventions which can be helpful for different problems when 
delivered in schools, such as anti-bullying programmes, psychoeducation, skills based interventions, 
working with parents and parent programmes.42 
                                            
35 Department of Health and NHS England (2015). Future in Mind: promoting, protecting and improving our children and young people’s mental 
health and wellbeing. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/414024/Childrens_Mental_Health.pdf 
36 Marshall, et al. (2017). Supporting Mental Health in Schools and Colleges: Quantitative Survey. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/634726/Supporting_Mental-Health_survey_report.pdf. White, et 
al. (2017). Supporting Mental Health in Schools and Colleges: Qualitative case studies. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/634728/Supporting_Mental-health_Case_study_report.pdf 
37 Young Minds (2014). Report on children, young people and family engagement for the Children and Young People’s Mental Health and 
Wellbeing Taskforce. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/413411/Young_Minds.pdf 
38 Kendall, Fonagy & Piling review – forthcoming. 
39 Eating disorders, self-harm behaviour, ADHD. 
40 Khan, et al. (2015). Investing in children’s mental health: A review of evidence on the costs and benefits of increased service provision. 
Centre for Mental Health. Available at: https://www.centreformentalhealth.org.uk/investing-in-children-report   
41 ibid 
42 Kendall, Fonagy & Piling review – forthcoming. 
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Furthermore, the literature provides evidence of general principles for effective implementation of mental health 
provision in schools to support high quality delivery.43 
While the evidence shows that schools can have a key role in supporting CYP mental health, both identifying need 
and providing interventions, it also shows that not all schools and their staff are currently able to deliver this.  
The most commonly used approach to identify pupils who may have mental health needs is ad-hoc identification 
based on concerns of members of staff, an approach which relies on staff knowledge and confidence. This was 
reported by 82% of schools.44 The majority of schools also reported using other means such as information from 
external agencies, assessment of mental health needs alongside other assessments and use of admin data. 
DfE’s 2016 Teacher Voice45 survey shows a mixed picture on how confident school staff feel about mental health 
and wellbeing: 
• While 57% of teachers feel equipped to identify behaviour that may be linked to a mental health issues, 
almost a quarter (23%) did not feel equipped; 
• 40% felt equipped to teach children in their class who have mental health needs, 34% did not; 
• 59% knew how to help pupils access support in the school, 22% did not.  
Evaluation of the Mental Health Services and Schools Link Pilots46 found that having leads in schools helped 
improve knowledge and confidence among staff and the range of provision provided by schools, when supported 
by a lead contact in NHS CYPMHS. Around half (49%) of schools currently have dedicated leads for mental health. 
For 69% providing training to staff is part of this role. More generally, 90% of schools report offering some 
training on mental health and wellbeing to their staff (47% say they offer training to all staff, 43% to some staff).47 
3. Policy objective;  
To increase support to children and young people (CYP) with mild to moderate mental health conditions in 
England, and to reduce the length of time that those who need specialist NHS Children and Young People’s 
(CYP) mental health services wait for treatment. 
The intended effects are: 
• To improve quality of life for CYP living with a mental health condition; 
• To improve outcomes for CYP living with a mental health condition; 
• To reduce the severity and impact of mental health conditions and thereby: 
o improve future earnings/productivity;  
                                            
43 ibid. 
44 Marshall, et al. (2017). Supporting Mental Health in Schools and Colleges: Quantitative survey. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/634726/Supporting_Mental-Health_survey_report.pdf. White, et 
al. (2017). Supporting Mental Health in Schools and Colleges: Qualitative case studies. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/634728/Supporting_Mental-health_Case_study_report.pdf 
45 Smith, et al (2017). NFER teacher voice omnibus. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/584503/Teacher_Voice_Summer_2016_Report_Final.pdf 
46 Day, et al. (2017). Mental Health Services and Schools Link Pilots: Evaluation Report. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/590242/Evaluation_of_the_MH_services_and_schools_link_pilots
-RR.pdf 
47 Marshall, et al. (2017). Supporting Mental Health in Schools and Colleges: Quantitative survey. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/634726/Supporting_Mental-Health_survey_report.pdf. 
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o reduce burden on the health and social care system; 
o reduce burden on the criminal justice system. 
4. Description of options considered (including status-quo); 
Option 1. Do nothing 
The counterfactual is the status-quo with no new national policies implemented. For the purpose of this Impact 
Assessment we have assumed need would remain at current levels. There is considerable uncertainty in this 
assumption given the latest nationally representative prevalence data was collected in 2004.48 These figures show 
that in 2004, 10% of children and young people aged 5-16 had a clinically diagnosable mental health disorder.49 
Emerging evidence provides a mixed picture on trends in prevalence of mental health problems but overall 
suggests that proportions of CYP with mental health issues may have increased since 2004, especially among 
young women and girls. 
• Surveys of adult mental health since 2000 have shown a steady increase in mental health issues, 
particularly amongst young women. Although not directly applicable to CYP, it does suggest increasing 
rates of mental health problems.50 
• An international study comparing mental health prevalence in 1990 and 2010 found that mental health 
difficulties, in particular anxiety and depression, had increased in developed countries, with the largest 
increases in adolescents and young adults.51 
• The Adult Psychiatric Morbidity survey reports a slight increase in the proportions of young women aged 
16-24 showing signs of depression and anxiety, but the rates for young men did not change substantially 
across the period.52  
Other research with population sub groups of CYP also indicate a possible increase in prevalence of needs: 
• Analysis on two cross-sectional (not nationally representative) cohorts of 11-13 year olds, showed an 
increase in emotional difficulties for girls between 2009 and 2014. Overall levels of difficulties, as 
measured with the Strengths and Difficulties Questionnaire (SDQ), did not change significantly, and there 
was a reduction in overall difficulties in boys.53  
• SDQ scores for 10 to 15 year olds reported as part of the ONS Children’s wellbeing measures however do 
not show a clear trend in the proportion with high SDQ scores (taken as an indicator of mental health 
issues) between 2009-10 and 2013-14.54  
• In 2015 26% of 15 year olds were indicated as being psychologically distressed, a very similar proportion 
                                            
48 Green, et al. (2005). Mental health of children and young people in Great Britain, 2004. Basingstoke: Palgrave MacMillan.  Available at: 
http://digital.nhs.uk/catalogue/PUB06116 
49Ibid. 3.3% had anxiety, 0.9% had depression, 5.8% had conduct disorder, 1.5% had hyperkinetic disorder, and 1.3% had a less common 
disorder (made up of 0.9% with autism spectrum disorder, 0.3% with an eating disorder, and 0.1% with mutism 
50 Children’s Commissioner (2017). Briefing: Childrens’ Mental Healthcare in England. Available at: 
https://www.childrenscommissioner.gov.uk/wp-content/uploads/2017/10/Childrens-Commissioner-for-England-Mental-Health-Briefing-1.1.pdf 
51 Fink, et al. (2015). Mental health difficulties in early adolescence: A comparison of two cross-sectional studies in England from 2009 to 2014. 
Journal of Adolescent Health, 56, 502-507. Available at: http://www.jahonline.org/article/S1054-139X(15)00064-6/pdf 
52Association for Young People’s Health (2017). Key Data on Young People, Chapter 6.  Available at:  
http://www.ayph.org.uk/keydata2017/FullVersion2017.pdf 
53 Fink, et al. (2015). Mental health difficulties in early adolescence: A comparison of two cross-sectional studies in England from 2009 to 2014. 
Journal of Adolescent Health, 56, 502-507. Available at: http://www.jahonline.org/article/S1054-139X(15)00064-6/pdf 
54ONS Childrens’ wellbeing measures data set. Available at: 
https://www.ons.gov.uk/peoplepopulationandcommunity/wellbeing/datasets/childrenswellbeingmeasures 
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to when the same measure was conducted in 2005. However this masks an increase in levels of 
psychological distress for girls, and a small reduction for boys between 2005 and 2014.55 
Option 2. Incentivise and support all schools and colleges to identify a Designated Senior Lead for Mental 
Health 
This role will be voluntary and will build on the 49% of schools and colleges which already have an identified lead 
for mental health.56 Decisions on who takes the role, how much time will be dedicated to the role and decisions 
around specific responsibilities and activities will be up to schools and colleges to decide and are likely to vary by 
factors such as the size of the setting, mix of other professionals on site and the needs of the pupils and students. 
As such schools and colleges will be able to decide what works for them. The evaluation of the school link pilot 
provides examples of approaches adopted by schools and colleges.57 The Green Paper sets out more detail on 
what the core roles of Designated Senior Leads for Mental Health are likely to be. 
In order to provide more support for existing Designated Senior Leads for Mental Health, to incentivise more 
schools and colleges to put leads in place and to ensure they have expertise and impact, two actions will be taken: 
• The first will be a national roll-out of the schools-CYPMHS link training to all areas. 
• The second will be to make funding available to leads for a suitable range of high quality training. The 
training fund will allow schools to choose appropriate training to build on skills and training the lead may 
already have. Training courses will be developed through Department for Education’s (DfE) Teaching and 
Leadership Fund (TLIF) to support training providers to develop training packages to build the skills of 
Designated Senior Leads for Mental Health. 
Option 3. Incentivise all schools and colleges to identify a Designated Senior Lead for mental health plus 
creation of new Mental Health Support Teams to provide support for those with mild to moderate mental 
health needs 
In addition to the Designated Senior Lead for Mental Health outlined in Option 2, new Mental Health Support 
Teams are proposed which will comprise trained staff offering focused evidence-based interventions, with 
appropriate clinical supervision.  This provision will be of particular benefit to children and young people who 
demonstrate mild/moderate conditions including: anxiety (primary and secondary school age), low mood 
(adolescents) and common behavioural difficulties. The Mental Health Support Teams will be linked to groups of 
schools and colleges, providing a clear link with, and support to Designated Senior Leads in schools and colleges 
and will build on existing good practice in support for CYP with mild to moderate needs.  
Teams will also have a wider role supporting all CYP, and will build on relationships with wider professionals in 
this area (e.g. health visitors, school nurses, school counsellors, third sector provision). We envisage that teams 
will also train other CYP professionals and support Designated Senior Leads for Mental Health in assessment and 
referral. 
There is expected to be a phased rollout of this policy. Initial implementation will be through a trailblazer 
approach, allowing local innovation, development and testing of different delivery models. The trailblazer 
approach will inform later phases of the rollout. The approach to the trailblazers will be informed by responses to 
the consultation on the Green Paper. 
                                            
55 Lessof, et al. (2016). Longitudinal Study of Young People in England cohort 2: health and wellbeing at wave 2. Department for Education. 
Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/599871/LSYPE2_w2-research_report.pdf  
56 Marshall, et al. (2017). Supporting Mental Health in Schools and Colleges: Quantitative survey. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/634726/Supporting_Mental-Health_survey_report.pdf 
57Day, et al. (2017). Mental Health Services and Schools Link Pilots: Evaluation report. Department for Health. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/590242/Evaluation_of_the_MH_services_and_schools_link_pilots
-RR.pdf 
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For the purpose of this analysis we have modelled a linear timeline to full rollout, shown below. This timeline is 
purely illustrative and does not reflect commitments.   
2018-19 2019-20 2020-21 2021-22 2022-23 2023-24 2024-25 2025-26 2026-27 2027-28 
5% 10% 15% 20% 25% 40% 55% 70% 85% 100% 
 
The new Mental Health Support Teams have not been considered as a stand-alone option without the Designated 
Senior Leads for Mental Health because the Leads will provide the crucial link between teams and schools and 
colleges and will have a joint role in the management of the teams, ensuring school needs are considered and 
met.  
Option 4: Options above plus CYPMHS waiting time pilots 
As well as investing in new Mental Health Support Teams and supporting and incentivising Designated Senior 
Leads for Mental Health in schools and colleges, we will pilot new service delivery models that are able to achieve 
reduced waiting times for access to NHS funded CYP’s mental health services to ensure that CYP with diagnosable 
mental health conditions receive faster access to the appropriate support that they require. The reduced waiting 
times will be piloted in some of the Trailblazer areas for the new Mental Health Support Teams.  
There is significant uncertainty around the expected cost to reduce waiting times. For example, there is 
uncertainty around the current prevalence of mental health disorders among CYP and the impact of the new 
Mental Health Support Teams on referrals to CYPMHS. Piloting the introduction of such a standard will enable us 
to make a fuller assessment of the costs and benefits of establishing a waiting time standard.  
The details of how these pilots will be implemented are under development with the geographical size and 
location, number of pilots and selection criteria still to be determined.  We expect they will be accompanied by an 
evaluation with central support. Evaluating the pilots will enable us to build a clearer understanding of costs, 
benefits and implementation challenges, as well as gathering and sharing best practice to feed back into 
services.    
Without investing in prevention and early intervention for mild to moderate mental health problems, as 
provided by Option 3, demand for CYPMHS services could continue to rise making it difficult to deliver a waiting 
time standard. Therefore, the waiting times pilots have not been considered as a stand-alone option. 
5. Monetised and non-monetised costs and benefits of each option 
(including administrative burden); 
Option 1: Do nothing 
As described above, due to an absence of up to date national data on prevalence for all disorders and ages on 
which to base assumptions of future prevalence, for the purpose of this assessment we have assumed the 
counterfactual is the prevalence of mental health disorders in CYP remaining stable at 10% over the evaluation 
period.  
The costs and benefits of not intervening are set at 0, and the costs and benefits of other options are assessed 
against this benchmark. 
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Option 2 Incentivise and support all schools and colleges to identify a Designated 
Senior Lead for Mental Health 
Costs 
All financial costs are associated with the provision of training for Leads. The cost of the roll out of the schools-
CYPMHS link training is estimated to be around £7.6m, likely to be spread over five years. To support the 
development of a suitable range of high-quality training, DfE will use their Teaching and Leadership Innovation 
Fund (TLIF) to support training providers to develop training packages to build the skills of Designated Senior 
Leads for Mental Health in schools and support the delivery of whole school approaches. The amounts to be 
provided to schools and colleges will be confirmed once the cost of what is developed is clear. However, we will 
aim to cover the costs of a significant training programme and provide up to £15-20m each year from 2019 to 
cover costs until all schools have had chance to train a Lead (assumed to be 5 years for this Impact Assessment). 
These costs and timings are still subject to change as implementation plans will be developed using responses to 
the consultation on the Green Paper. These indicative costs have been included for the purposes of completing 
this Impact Assessment, and the central estimate of £17.5m per year has been used as the descriptive training 
cost in the modelling. The sensitivity of the total costs of the Option to the annual cost being £15m or £20m has 
been explored in the sensitivity analysis – see Sensitivity Analysis section. 
Therefore, we have assumed that the total cost of Option 2would be: 
Total cost of Option 2, in £m, rounded to the nearest £0.5. Total present value cost: £83m 
  2018- 2019 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 
Joint school 
link 0 
1.5 1.5 1.5 1.5 1.5 
Lead training 0 17.5 17.5 17.5 17.5 17.5 
 Total cost 
(undiscounted) 0 
19 19 19 19 19 
Total present 
value cost58 0 
17.8 17.1 16.6 16.0 15.5 
 
Unquantified costs 
The evaluation of the first schools-CYPMHS  link pilot59 did not indicate an impact on referral numbers to 
CYPMHS, but we cannot be certain  of whether scaling up and wider rollout of the programme will have an impact 
on referrals. However, we do not anticipate that this option would have a significant impact on workload for 
CYPMHS (the pilot evaluation cautiously identified that there was not an increase in CYPMHS referrals overall and 
found that in many areas the programme contributed towards a reduction in referrals to CYPMHS for children 
who do not meet the threshold for specialist treatment). However, there is a risk that, without the additional 
support, proposed to be provided via Mental Health Support Teams as part of option 3, there could be an 
expectation that schools provide support that may not have the capacity and expertise for. 
                                            
58 We have discounted the costs and benefits throughout the IA to the current year (2017/18). Discounting is based on the principle that, 
generally, people (and society as a whole) prefer to receive goods and services now rather than later. The discount rate is used to convert costs 
and benefits falling in different time periods to ‘present values’, so that they can be compared. For an explanation of discounting throughout this 
document, please see the Green Book at 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/220541/green_book_complete.pdf 
59 Day, et al. (2017). Mental Health Services and Schools Link Pilots: Evaluation report. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/590242/Evaluation_of_the_MH_services_and_schools_link_pilots
-RR.pdf 
 17 
 
 
There is an opportunity cost of the time spent by Designated Senior Leads for Mental Health on the roles, which 
could otherwise be spent on different tasks. However, we have not quantified this opportunity cost for a number 
of reasons:  the role is voluntary, the time spent would be determined by individual schools, and we currently 
have no evidence of the benefits of other tasks that would otherwise be completed. 
Similarly, the time Leads spend training could be spent on other training activities. We have not quantified this 
opportunity cost as we do not yet know how much time Leads will spend training. The amount of training 
required depends on individual need, and the requirements of the school or college. The grading of the individual 
taking the Lead role could vary from an assistant teacher through to a Senior Leadership Team (SLT) grade. 
Furthermore, we expect that all school staff undertake continuing professional development (CPD) within their 
role, and we do not have information on the benefits of any training that would otherwise have been completed.  
Wage costs could be used to calculate this opportunity cost, however given the high level of uncertainty as 
outlined above we are not able to robustly quantify the size of this opportunity cost. To give an indication of the 
scale of this cost, depending on the grade of the Designated Senior Lead, we have instead calculated a range of 
minimum opportunity costs associated with attending one full day of training, based on salary costs across the 
different grades.  
Grade 
1 full day of 
training60 
Hourly 
wage616263 
Total opportunity cost of 
training 
Classroom teacher 
(MPR)64 6.5 £29.32 £190.18 
Classroom teacher (UPR) 65 6.5 £38.65 £250.75 
Lead practitioners 6.5 £48.12 £312.19 
Assistant Head 6.5 £51.81 £336.13 
Deputy Head 6.5 £56.05 £363.61 
Head 6.5 £69.17 £448.73 
Benefits 
We anticipate that schools and colleges identifying Designated Senior Leads for Mental Health, a further roll-out 
of the schools-CYPMHS link training, and the associated training for Designated Senior Leads, will lead to benefits 
for CYP mental health, teachers, schools and colleges and the wider system.  
 The evidence from the evaluation of the first school-CYPMHS link pilot66 and the survey on supporting mental 
health in schools and colleges67 suggests that better school and specialist services links would likely lead to 
increased knowledge of respective issues and pressures and improved communication, and together with better 
identification and assessment of need will be associated with improvements in referral pathways leading to more 
appropriate and timely referrals.  
Having better informed, more knowledgeable Leads would likely have a positive impact on CYP outcomes through 
increased attention to mental health in the curriculum, staff training and related staff confidence in supporting 
                                            
60 Assuming an average working day of 6.5 hours. 
61 We have taken an average of salaries across primary and secondary school. 
62 These figures include on-costs (include employers' pension (16.48%) and national insurance contribution). 
63 All costs are given in 2017/18 prices; they are subject to increases across the life of the policy predicted at a 1% increase rate.  
64 MPR – Middle pay range 
65 UPR – Upper pay range 
66 In the first school and NHS CYPMHS link pilot, a total of 22 areas, incorporating 27 CCGs and 255 schools, were funded to establish named 
Lead contacts within NHS CYPMHS and schools. They also participated in 2 joint planning workshops, involving other professionals from their 
local NHS CYPMHS network. Day, et al. (2017). Mental Health Services and Schools Link Pilots: Evaluation report. Department for Education. 
Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/590242/Evaluation_of_the_MH_services_and_schools_link_pilots
-RR.pdf 
67 Marshall, et al. (2017). Supporting Mental Health in Schools and Colleges: Quantitative survey. Department for Education. Available at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/634726/Supporting_Mental-Health_survey_report.pdf 
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pupils. Schools would likely have more activities in place to promote positive mental health and more support for 
pupils with identified health needs. Higher levels of engagement with parents are also anticipated.  
Furthermore, we assume that additional training and access to support through Leads will improve the mental 
health knowledge of teachers and wider school and college staff, making them more able to spot the first signs of 
mental health issues. We also expect wider impact on the school and colleges environments in terms of whole 
school/college approaches and as part of their pastoral systems.  
The above assumptions on the outcomes and impacts of the wider roll-out of school/college and CYPMHS links 
are based on the evidence from the first phase of the pilots and the survey on provision of support in schools. 
Additional evidence will be gathered through the evaluation of the Phase 2 school/college-CYPMHS link pilot and 
will be further tested through the evaluation of the proposed Trailblazers, described above in relation to Option 3. 
In addition, the Trailblazers will be able to provide further insight on the impact of the model on overall number 
of referrals from schools to CYPMHS.  
Option 3: Incentivise all schools and colleges to identify a Designated Senior Lead 
for mental health, plus creation of new Mental Health Support Teams to provide 
support for those with mild to moderate mental health needs 
Costs 
This option will include the costs estimated for Option 2, which were quantified as £83.0m in total present value 
cost.  
In addition, it is estimated that nationally approximately 8,000 FTE would be employed within the Mental Health 
Support Teams at an annual financial cost of £360m (at full roll out). 
Each team will vary in terms of staff numbers and seniority dependent on the schools and colleges that it serves. 
We would anticipate that teams would be mostly comprised of practitioners (band 4/5/6) with supervisors and 
management (bands 7/8) and admin support. 
This is an appropriate level of staffing to provide an offer of support to children with mental health needs 
according to clinical advice.  The exact staffing ratios will of course need to be determined according to local 
circumstances, and will be informed through responses to the Green Paper consultation and will be tested by 
initial Trailblazer sites.  
Total costs include 28% on-costs, 20% overheads, and training costs for the new workforce of c. £8m per annum 
for the first 9 years. 
For the purposes of this analysis, we have estimated the following annual costs of Mental Health Support Teams 
over the next ten years.  This rollout profile is illustrative only, and long-term funding will clearly be subject to 
future spending reviews: 
Total cost of Mental Health Support Teams, in £m, rounded to the nearest £0.5m.  
Total present value cost: £1,223m 
Year 
2018-
19 
2019-
20 
2020-
21 
2021-
22 
2022-
23 
2023-
24 
2024-
25 
2025-
26 
2026-
27 
2027-
28 
Rollout 5% 10% 15% 20% 25% 40% 55% 70% 85% 100% 
Total cost 
(undiscounted) 18.0 36.0 54.0 72.0 90.0 144.0 198.0 252.0 306.0 360.0 
 19 
 
 
Total present value 
costs 18.0 34.8 50.4 64.9 78.4 121.2 161.1 198.1 232.4 264.1 
 
Unquantified costs 
Unquantified costs would include those described for Option 2. Additionally, there would be opportunity costs of 
CYP spending time taking part in interventions: the learning that could have taken place, and its associated 
benefits. However, it is not possible to robustly quantify these costs, given the school-specific approach that will 
be taken in offering interventions. For example, the opportunity cost would differ depending on when the 
interventions take place, such as during teaching time, before/after school, or during break times. Additionally, 
CYP who take part in interventions may be a non-representative set of pupils who are more likely to be absent 
from school/college, e.g.  who are more frequently ill. 
There may also be a cost burden on CYPMHS if the number of referrals requiring treatment rises due to more 
accurate identification and assessment of children with mental health conditions. However, we expect that the 
earlier intervention provided by new Mental Health Support Teams would eventually reduce this impact.  We 
have not quantified this impact at this stage and will look to Trailblazers to examine this in more detail. 
Total quantified costs 
The total quantified costs of Option 3 are therefore estimated as follows: 
Total cost of Option 3, £m, rounded to the nearest £0.5m.  
Total present value cost: £1,265m 
  
2018-
19 
2019-
20 
2020-
21 
2021-
22 
2022-
23 
2023-
24 
2024-
25 
2025-
26 
2026-
27 
2027-
28 
 Total cost 
(undiscounted) 18.0 55.0 73.0 91.0 109.0 163.0 198.0 252.0 306.0 360.0 
 Total present value 
cost  17.4 51.4 65.9 79.3 91.8 132.6 155.6 191.4 224.5 255.2 
 
Benefits 
In addition to the benefits of Option 2, there would be health and wider societal benefits from the interventions 
delivered through Mental Health Support Teams.  
As Support Teams, with input from schools and colleges, will have discretion over specific interventions delivered 
(the most appropriate interventions will depend on the local context), we have quantified the magnitude of the 
expected benefit using an illustrative sample of targeted interventions for children with mild to moderate mental 
health conditions, for which good evidence of impact exists. While this analysis provides us with estimates of 
benefits of this Option, it is not exhaustive in the interventions included and relies on many assumptions. 
Therefore, it is important to note that the presumed benefits below are limited by the assumptions made.  
We would expect support teams to deliver targeted interventions in schools that either 
i) have evidence of being cost-effective, or  
ii) ii) are innovative interventions with emerging evidence about effectiveness or cost-effectiveness. 
iii) In either case, we would expect teams to monitor and evaluate the impacts, and we intend to 
commission a central evaluation of the Trailblazers which will also consider the effectiveness of the 
interventions employed by teams. 
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Benefits of targeted programmes/interventions by teams 
In order to estimate illustrative benefits of delivering interventions by the Mental Health Support Teams, we have 
used evidence of cost-effectiveness of established specialist programmes.  
We are defining specialist interventions as interventions or therapies that are delivered by a mental health 
professional and that are targeted to address a certain condition or need. An example would be cognitive 
behavioural therapy, either in 1:1 sessions or in a group. 
Other support could take a variety of forms, and not necessarily an intervention delivered by a mental health 
professional. This support would offer advice and counsel to children with a need, and may possibly include 
interventions delivered by trained teachers and school staff.  
For the cost benefit analysis we have been able to consider evidence for the following established specialist 
interventions:  
Conduct disorder: Aggression Replacement Therapy (ART)  
Anxiety and Depression: Cognitive Behavioural Therapy (CBT) 
ADHD: Incredible Years Parent Training 
These interventions are recommended as cost-effective by the Centre for Mental Health (2013)68. We have 
applied benefits as estimated by Dartington’s Social Research Unit’s Investing in Children work (2013).69 As we are 
consulting on the details of the policy, the benefits of these interventions should be treated as illustrative benefits 
of the Option, and we do not know at this point which interventions will be delivered by teams, and effectiveness 
of treatments are likely to vary70. 
Adapting the academic cost effectiveness estimates to calculate benefits 
Dartington’s Social Research Unit provides estimates of impacts specifically for the UK. These are based on the US 
Washington State Institute for Public Policy (WSIPP) model for the US71. This model uses meta-analysis to 
estimate the short-term impacts of interventions on short-term outcomes such as test scores or diagnosis with a 
mental health disorder. The meta-analysis considers international evidence, and as such, estimated short-term 
impacts are not specific to the UK. However, Dartington’s work then estimates long-term impacts specifically for 
the UK context.   
The analysis uses longitudinal data to predict the lifetime effects of the short-term impacts in order to estimate 
the long-term benefits of interventions on the UK economy, through NHS usage, the justice system, and earnings. 
The model estimates the impact on earnings through two different pathways: the impact of increased educational 
attainment on earnings, as well as the impact of improved health on reductions in sickness absence.  
The healthcare use counterfactual modelled throughout the model is the usual treatment that would occur in the 
absence of these interventions, estimated through various surveys. The healthcare resources costed include 
contact with paediatricians, paediatric inpatient stays, community nurses, school nurses, dieticians, 
physiotherapists, occupational therapists, speech therapists, and visits to A&E. The model covers the following 
disorders: conduct disorder, depression, anxiety, ADHD. 
                                            
68 Khan, et al. (2015). Investing in children’s mental health: A review of evidence on the costs and benefits of increased service provision. 
Centre for Mental Health. Available at: https://www.centreformentalhealth.org.uk/investing-in-children-report 
69 http://investinginchildren.eu/ 
70 Weisz, et al. (2017). What five decades of research tells us about the effects of youth psychological therapy: A multilevel meta-analysis and 
implications for science and practice. American Psychologist, 72(2), 79 – 117. 
71 The Social Research Unit at Dartington (2013). Investing in Children: Technical Report. Available at: 
http://investinginchildren.eu/reports/Investing%20in%20Children%20-%20Technical%20Report%20(September%202013).pdf 
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There will be benefits to other government departments (OGDs) from these interventions. Increased earnings will 
increase tax receipts, benefitting HMRC, and decrease reliance on social support, benefitting Department for 
Work and Pensions. Reduced crime will generate savings to the Home Office and Ministry of Justice. 
The model outputs are estimated savings to the NHS, benefit of increased earnings, and savings due to decreases 
in crime. The model relies on improvements in health (which is measured by looking at quality and quantity of 
life) to quantify these outputs. Typically, these improvements would be monetised using ‘quality adjusted life 
years’, or QALYs (a generic measure of health status, or health gain). However we are not able to calculate QALYs 
for these interventions, and so we cannot monetise the impacts/improvements in health in this model72. Instead, 
we have used the estimates from the research above to estimate the average indirect benefit of NHS savings and 
productivity improvement, for each disorder considered.73 74 It is estimated that additional funding to the NHS 
would result in one QALY purchased for each additional £15,000. There is also evidence that one QALY is valued 
by society at £60,000. Therefore, each £1 saved in the NHS will generate £4 worth of benefits, and we have 
accounted for this in our estimates of the value of NHS savings throughout this document. The estimates are 
shown in the table below: 
Estimated benefits of different interventions, per child participating in an intervention rounded to the nearest £100 
Type of illness NHS saving (£) Productivity (£) 
Conduct disorder - ART 0 4,500 
Anxiety - CBT 10,500 5,400 
Depression - CBT 8,500 5,400 
ADHD - Incredible Years parent training, primary participant 200 300 
ADHD - Incredible Years parent training, secondary participant 1,500 600 
Average 4,200 3,200 
While there will also be benefits to government and society of reductions in crime, we have chosen not to use 
estimates from this model, because we have judged these as not sufficiently robust due to the underlying data on 
the number of offences and sentences received being out of date. 
As previously mentioned, Mental Health Support Teams and the schools and colleges they work with would have 
discretion over which interventions they choose to implement.  
Due to this uncertainty, we cannot estimate the specific cost-effectiveness of the whole range of interventions 
Support Teams would deliver. We expect Support Teams would implement effective programmes from the 
beginning, and improve in their effectiveness as learning improves. However, given the absence of evidence, we 
have halved the benefits in order to be conservative in our approach and account for this uncertainty. We have 
used the average benefit in each domain across all interventions considered. This is due to a lack of evidence 
about the number of cases of each different disorder we expect to be treated as well as the broad range of 
estimates for the benefits of different interventions. 
Further, estimates from the UK are difficult to obtain and there is significant discrepancy between recovery rates 
internationally and the UK. Estimates of rates of improvement in the groups targeted are also higher when 
                                            
72 Quality adjusted life years, or QALYs, are a measure of health status or health gain. One QALY is one year of life in full health, 2 years of life 
at half of full health is also equivalent to one QALY. The benefit of a health policy or intervention is measured in terms of QALYs generated. It is 
estimated that one QALY is worth £60,000 
73 Benefits in adulthood from interventions in childhood are always difficult to estimate robustly, and we will continue to review the possibility of 
double-counting and the best way to estimate as accurately as possible. 
74 The base year for monetary values in this model is 2011. We have therefore inflated this to 2016/17 prices using the GDP deflator. The base 
discount rate used is 3.5% p.a. The costs and benefits are assessed over a person’s lifetime.  
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considering RCT evidence compared observations in unselected presentations to CYPMHS. This is another reason 
why we halve the benefits to account for this uncertainty. 
Therefore, our best estimate for the benefits in each domain is shown in the below table: 
Estimated benefits of each domain, per child participating in an intervention rounded to the nearest £100 
NHS saving (£) 2,100 
Productivity (£) 1,600 
To estimate the total benefits of these interventions, we estimate the number of CYP with a diagnosable mental 
health condition who would receive a specialist intervention from the new teams.  
We estimate that of those CYP with a diagnosable mental health condition who are not currently referred to 
CYPMHS services, 60% would require specialist support (470k). We have made a further (conservative) 
assumption that 60% of that group will receive specialist support from the new Mental Health Support Teams 
(280k), in order to be able to quantify the benefits of the teams75.  
In addition, we assume 50% (45k) of those currently receiving only one CYPMHS contact will receive specialist 
support from the new Mental Health Support Teams. Hence, for the modelling of the benefit we have assumed 
the teams will offer specialist support to 325k children with a diagnosable health condition.  
325k is only a partial estimate of the total number of CYP who we expect will be supported by the new teams. The 
groups of CYP who are anticipated to receive support from Mental Health Support Teams are shown in the 
diagram below: 
 
 
 
 
 
 
 
 
 
 
 
 
 
There is a significant number of CYP with a need that would benefit from non-specialist support from Support 
Teams, but because the evidence we are using focuses on the benefit of specialist interventions for CYP with a 
diagnosable condition, we have not monetised the benefit of non-specialist support.76  
                                            
75 Assumptions are based on conversations with clinical experts: Professor Miranda Wolpert, Professor Stephen Pilling, Professor Tim Kendall, 
and Professor Peter Fonagy. 
76 Based on estimated prevalence from Green, et al. (2005). Mental health of children and young people in Great Britain, 2004. Basingstoke: 
Palgrave MacMillan. Available at: http://digital.nhs.uk/catalogue/PUB06116   
Assumptions are based on conversations with clinical experts (Professor Miranda Wolpert, Professor Stephen Pilling, Professor Tim Kendall, 
and Professor Peter Fonagy). 
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Due to a lack of evidence of the prevalence of lower level needs we have also not made an estimate of the 
benefits for the number of CYP with lower level needs but without a diagnosable condition. In the absence of the 
policy, these CYP would not be referred to CYPMHS and would not receive support, but they would likely be 
supported by the new Mental Health Support Teams and benefit from improved quality of life. 
Note that the costs of the Mental Health Support Teams have been estimated with the aim of creating sufficient 
capacity to both CYP who need specialist support (quantified) and those who would receive non-specialist 
support (not quantified) (see the Sensitivity Analysis section for the impact of a larger number of children 
receiving specialist support from teams). 
We have applied the average saving in each domain above for each of the 325,000 CYP estimated to receive 
specialist support from Mental Health Support Teams. In the counterfactual we assume that none of these CYP 
would have received the same benefit from other services (CYPMHS, voluntary sector) – we vary this assumption 
in the sensitivity analysis (see Sensitivity Analysis section). 
Total quantified benefit of Option 3: Estimated discounted benefits of Mental Health Support Team interventions, 
in £m, rounded to the nearest £0.5m.  
Total present value benefit: £3939m 
  2018 - 19 
2019 - 
20 
2020 - 
21 
2021 -
22 
2022 - 
23 
2023 - 
24 
2024 - 
25 
2025 - 
26 
2026 - 
27 
2027 - 
28 
% rollout 5% 10% 15% 20% 25% 40% 55% 70% 85% 100% 
Number of CYP 
receiving an 
intervention 
(thousands) 
                                                       
16,250  32,500  
48,750  65,000  81,250  130,000  178,750  227,500  276,250  325,000  
NHS saving from 
interventions 
33.8 67.7 101.5 135.4 169.2 270.8 372.3 473.8 575.4 676.9 
Productivity 
from 
interventions  
26.1 52.3 78.4 104.6 130.7 209.1 287.5 365.9 444.4 522.8 
Total benefit 
(undiscounted)  
60.0 120.0 180.0 239.9 299.9 479.9 659.8 839.8 1019.7 1199.7 
Total present 
value benefit 
58.0 112.0 162.3 209.1 252.5 390.4 518.6 637.7 748.2 850.5 
 
Unquantified benefits 
Impact on CYPMHS 
The Mental Health Support Teams may have an impact on the number of CYP with severe conditions who are 
referred to and treated in CYPMHS.  In the short-term demand for specialist services may increase as 
identification and referral of CYP with serious needs may increase. We have not quantified the health (or wider) 
benefits resulting from additional CYP being treated by CYPMHS as we do not have evidence for the magnitude of 
this effect.  
It could also impact the number of CYP who are currently referred and do not meet the threshold for specialist 
treatment. In the long-term, we would expect referrals to CYPMHS to decrease as CYP’s disorders are dealt with 
at an earlier stage, better self-managed, and are stopped from reaching a crisis point. This would reduce the 
burden on CYPMHS. However, we would always expect there to be a proportion who still need specialist support. 
The Trailblazers will allow for evaluation of this impact, in the meantime we leave this impact un-monetised but 
estimate an illustrative per-child benefit of treatment in CYPMHS, for CYP with severe conditions who would be 
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identified as needing CYPMHS treatment by Mental Health Support Teams, who would then be treated by 
CYPMHS These estimates can be found in the Annex. 
Other unquantified benefits 
There are a number of areas where we might expect improvements to be seen, however we have not found 
robust evidence of these effects to allow these to be quantified: 
• We have not quantified the benefits to CYP with mild and moderate needs that are likely to receive other 
(non-specialist) support from Mental Health Support Teams, which we believe represents the majority of 
CYP with unmet need. They are likely to benefit in terms of short term and long term outcomes but as the 
evidence available focuses on specialist support, we have limited our analysis to those that we expect to 
receive these specialist interventions from Mental Health Support Teams. 
• The health gains that would result from improved quality and quantity of life for CYP as a result of the 
new Mental Health Support Teams.  
• The health benefits to carers if their anxiety decreases due to their child receiving treatment, if the child 
would otherwise have not received treatment. While we have estimated savings to the NHS, it is also 
plausible that there may be savings in future social care costs, falling to individuals and local authorities.  
• In addition, there may be improvements in physical health – as outlined above, individuals with mental 
health disorders have an increased risk of physical health conditions. We have not quantified these due to 
a lack of evidence.  
• We would also anticipate impacts on a number of other outcomes including some shorter-term cost 
savings to the school system. For example, pupils with mental health problems were 17 times more likely 
to be excluded from school.77 This is indicative of wider behaviour and conduct problems, which can 
disrupt the pupil’s education, their peers’ education, and have costs to teachers and schools relating to 
the management of these problems. New Economy Manchester estimated that the economic cost of 
exclusion was £9,748 per person, per year.78  
• Similarly, according to teachers, CYP with mental health issues are 7.5 times more likely to truant.79 New 
Economy Manchester estimated that the total societal cost associated with truancy was £2,351 per 
person, per year.80 There is also likely to be less pressure on special education needs and disability (SEND) 
services. 
Whilst the fiscal and economic benefits associated with these outcomes are sizable, we exclude these from our 
quantified estimates, for two reasons. First, robust evaluations of the causal impact of mental health 
interventions on truancy and exclusion are unavailable. Second, the economic returns associated with truancy 
and exclusion in part stem from improved attainment and productivity – to the extent that these impacts are 
already captured in the benefits estimates, there is a risk of ‘double counting’.  
However, it should be noted that the benefits to a pupil’s peers, their teachers, and their school are likely to yield 
a significant economic return, over and above those captured in the benefits calculation.  
                                            
77 Meltzer, et al. (2003). Persistence, onset, risk factors and outcomes of childhood mental disorders. Available at: 
http://webarchive.nationalarchives.gov.uk/+/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsStatistics/DH_4081089 
78 New Economy Manchester, Unit Cost Database *Costs are in 2015/2016 prices 
79 Meltzer, et al. (2003). The mental health of children and adolescents in Great Britain. International Review of Psychiatry, 15(1-2),185-7. 
Available at: https://www.ncbi.nlm.nih.gov/pubmed/12745331  
80 New Economy Manchester, Unit Cost Database *Costs are in 2015/2016 prices 
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Option 4: Incentivise all schools and colleges to identify a Designated Senior Lead 
for mental health, plus creation of new Mental Health Support Teams to provide 
support for those with mild to moderate mental health needs, plus pilot new 
service delivery models to reduce waiting times in CYPMHS 
Costs 
We expect the CYPMHS waiting times pilots will be supported by funding and an evaluation.  For the purpose of 
this analysis, we assign a total cost of c. £50m81 between 2018/19 to 2020/21.  Long-term funding is subject to 
future spending reviews. 
The details of how pilots will be funded are also to be determined.  We are seeking views on what criteria should 
be used to choose the pilot areas, but to make the pilot as successful as possible we will want to select a variety 
of areas to represent areas with differing waiting time (from long waiting times to shorter ones) in order to best 
help assess the benefits and challenges and provide information on how the waiting time standard should be 
adapted before being rolled out nationally. We will release more information on the selection of areas and the 
phasing of the implementation following the consultation period. 
Therefore, the total cost of Option 4 would be: 
Total cost of Option 4, in £m, rounded to the nearest £0.5m.  
Total present value cost: £1,309m 
  
2018 - 
19 
2019 - 
20 
2020 - 
21 
2021 -
22 
2022 - 
23 
2023 - 
24 
2024 - 
25 
2025 - 
26 
2026 - 
27 
2027 - 
28 
Total cost 
(undiscounted) 26.0 75.0 93.0 91.0 109.0 163.0 198.0 252.0 306.0 360.0 
Total present 
value cost 25.1 70.0 83.9 79.3 91.8 132.6 155.6 191.4 224.5 255.2 
Benefits 
Piloting approaches to achieve shorter waiting times will allow us to make a fuller assessment of the feasibility of 
establishing a waiting time standard.  
It is assumed that piloting a waiting times standard will decrease waiting times, and therefore there would be a 
quality of life gain for the individual for the period of time that they are no longer waiting. We expect that there 
will also be a substantial benefit to CYP waiting for treatment, as well as their families, of reduced anxiety and 
distress while waiting. Caution is required however to ensure waiting times are not reducing through a reduction 
in quality or overall access. 
If diagnosis and treatment can lead to a sustained improvement in quality of life, there is also a benefit derived 
from the reduction in the amount of time CYP experience a lower quality of life.  There is limited evidence around 
the impact of reduced waiting times on long term outcomes. However, we expect that reducing waiting time 
would result in better engagement with treatment, and a decreased risk of deterioration while waiting. Therefore 
it is plausible that it will increase the probability of a sustained improvement in health following treatment. It may 
also result in savings to the NHS if it prevents CYP from going into inpatient care. 
                                            
81 Estimate of the cost to be on track to deliver a reduced waiting time for 20-25% of the country by end of 22/23, as detailed in the Green 
Paper, this is based on stock and flow modelling of current activity (best estimate based on 16/17 MHSDS data and 2016 NHS Benchmarking 
data) and future activity (conservative estimate that referrals will increase by 10% per annum). There are significant uncertainties around these 
estimates, for this reason they are purely illustrative to indicate a scale of cost, more accurate information will be generated through the pilots. 
 26 
 
 
We have not monetised the benefit of a reduction in waiting time, but look to the evaluation of the waiting time 
pilots to inform the impact if rolled out nationally. This is due to uncertainty around the number of weeks that 
average waiting times will reduce by, as this is dependent on the areas in which the pilots take place. Our break-
even analysis found that six weeks is the minimum amount of weeks that average waiting times would have to 
reduce by (in the pilot areas) in order for the benefit to outweigh the cost. In this analysis, we have only 
considered the benefit to CYP from the reduction in the proportion of their life they spend with pre-treatment 
quality of life. As there will be other benefits, mentioned above, six weeks is an over-estimate, and the number of 
weeks that average waiting times need to reduce by in order to cover the cost will likely be lower. Given the 
ultimate ambition of all CYP being seen within four weeks, and the current average waiting time of 12 weeks, we 
believe it is very likely that the benefits of the waiting times pilots will outweigh their costs.  
The detailed calculations for this break-even analysis can be found in the Annex. 
Given the uncertainty around the number of weeks that average waiting times will reduce by we have not been 
able to quantify the expected benefits. Therefore, the total quantified benefit of Option 4 is equal to the total 
quantified benefit of Option 3.  
Risks  
There are risks of applying the evidence we have used to the benefits of the policies above. 
1. Dartington’s simulation model uses estimates of impacts from the US, which may not be applicable to the UK 
context. In addition, we have not been able to find evidence for treatments of all mental health conditions, 
and we have not been able to weight the evidence on treatments we have found by the relevant prevalence 
rates, due to lack of information of the relative prevalence of disorders by severity, and some CYP having 
more than one mental health disorder. 
2. There is a risk that our approach of taking the average impact of a variety of interventions, in Option 3, is not 
appropriate. The effectiveness of interventions will vary based on the condition considered, the severity, and 
other contextual factors. We have pursued a simplistic approach to attempt to estimate the magnitude of the 
impact we can expect from the policies, due to a lack of specific evidence.  
3. Policy Option 2 assumes that schools and colleges will be incentivised to identify a Designated Senior Lead for 
Mental Health and that Leads will be able to take up the training offer. 
4. Policy Options 3 and 4 require a large expansion in the mental health workforce, the analysis presented 
assume that this demand can be met. 
5. For Options 3 and 4, we have not been able to quantify the impact of the schools’ service on CYPMHS. While 
we expect these options to decrease demand for CYPMHS in the long-run, there is a lack of evidence around 
the short-term impact. 
6. The costs and benefits are highly sensitive to the assumption that in the counterfactual, prevalence remains 
stable at the latest measured levels. There is a risk, based on indicative evidence, that prevalence has 
increased. 
Sensitivity analysis  
We have undertaken sensitivity analysis around the assumptions affecting the quantified benefit of Options 3 and 
4. We have varied the assumptions in the table below: 
Options 3 and 4 quantified benefits assumptions 
PV benefits, 
central case 
PV benefits, 
low case Low 
NPV 
PV benefits, 
high case 
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1. Adjustment to average benefit:cost ratio to account for 
uncertainty in interventions chosen 50% 50% 100% 
2. Number of CYP receiving targeted intervention in school 
                         
325,000  162,500    515,000  
3. Percentage of CYP who would have got the same benefit 
in CYPMHS 0% 5% 0% 
 
Firstly, we have modelled a best case scenario of all interventions delivered being cost-effective at the rate 
estimated by Dartington’s Social Research Unit (100% effectiveness). Giving us a central and higher estimate of 
the benefit, we have not modelled a lower estimate here. 
We have also varied assumption 2 by increasing the number of CYP receiving targeted intervention in schools to 
515,000 (based on 100%82 of CYP currently not referred to CYPMHS who would benefit from specialist treatment 
receiving it from Mental Health Support Teams). We have also halved our central assumption of 325,000, to 
account for uncertainty in the current and future prevalence of mental illnesses in CYP. This gives us a lower, 
central and higher estimate of the benefit. 
In addition, we have modelled the case of 5% of CYP from whom we quantify benefits in Options 3 and 4 being 
otherwise treated by CYPMHS and therefore gaining no additional benefits from the policy. This gives us a low 
and central estimate; here we have not modelled a high estimate.  
The resulting estimated benefits in the case of varying each assumption separately is shown below: 
Options 3 and 4 benefits – sensitivity analysis PV benefits, low case (£) PV benefits, high case (£) 
Adjustment to average benefit:cost ratio to account for 
uncertainty in interventions chosen 3939m 7879m 
Number of CYP receiving targeted intervention in school 2024m 6242m 
% who would have got the same benefit in CAMHS 3742m 3939m 
 
We have also varied the assumptions together, taking the ‘best case’ as all inputs falling halfway between the 
best and central case scenarios, and the ‘worst case’ as all inputs falling halfway between the worst and central 
case scenarios. The results are shown in the table below: 
 
PV benefits, low case 
(£) 
Present value benefits, high case 
(£) 
Adjustment to average benefit:cost ratio to account 
for not all policies being cost effective 
2907m 7636m Number of CYP receiving targeted intervention in 
school 
% who would have got the same benefit in CAMHS 
 
We have also undertaken sensitivity analysis around the assumptions affecting the quantified costs of Option 2. 
From the Schools-CYPMHS link pilot, we can estimate that the cost of the roll out of the schools-CYPMHS link 
training is around £7.6m, likely to be spread over five years. However, there is less certainty around the cost of 
Lead training. This cost is subject to change as implementation plans are developed. In order to provide a more 
accurate range of costs we have taken a lower, central and higher estimate of this cost.  
If the annual costs are £15m, the present value cost of Option 2 is £70.8m. If the annual costs are £20m, the 
present value cost of Option 2 is £93.8m. 
                                            
82 Advice from clinical leads is that this is not an accurate assumption based on experience – there is an overlap of cases 
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There is also uncertainty around the cost of Options 3 and 4. However, the main uncertainty is around the 
efficiency of the labour input in the staffing cost model (i.e. how many CYP one FTE can support). The main effect 
of varying this assumption will be changing the number of CYP that can be supported, and this has already been 
analysed in the sensitivity analysis of the benefits above. 
Conclusion 
Given the conservative approach taken in estimating the monetised benefits and the potential scale of the un-
monetised benefits, we consider it reasonable to support that all options outlined in this assessment are cost-
effective. 
Areas of evidence/information/assumptions that can be further 
informed through consultation  
We have considered the available published evidence in order to form evidence-based assumptions throughout 
this IA. During the Green Paper consultation period, the Department of Health aims to further develop the 
evidence base for the policy by consulting with relevant stakeholders and inviting recommendations for further 
evidence that may strengthen our analysis of impact. 
The key topics on which we want to consult, and the existing evidence on which assumptions have been based, 
are: 
Evidence on the proportion of CYP with diagnosable mental health disorders who would benefit from 
support from the Mental Health Support Teams.  
Current evidence from discussion with academics and clinicians 
Evidence on the proportion of CYP with pre-diagnosable mild to moderate mental health problems who 
would benefit from support from Mental Health Support Teams.  
We currently have no robust evidence on levels of need for this group 
Evidence on the impact on mental health and wider outcomes of interventions for CYP with mild to 
moderate mental health needs, as could be delivered by the Mental Health Support Teams  
Current evidence drawn from a small set of interventions and Dartington’s Social Research Investing in 
Children report 
Evidence on the impact of CYPMHS therapeutic treatments 
Published literature on the cost-effectiveness of treatments in CYPMHS 
We welcome references to any evidence, published or in development, or expert opinion on the topics set out 
above to help refine this Impact Assessment. To respond to the consultation, you can complete the online 
consultation questions at www.engage.dh.gov.uk/youngmentalhealth 
The questions will follow on from the main Green Paper consultation questions. The consultation is now live and 
will be open for 13 weeks, in accordance with Cabinet Office guidelines, and close at midday on 2 March 2018. 
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Annex 
QALY benefit of NHS CYMPHS treatments for anxiety or depression 
We have found studies on the effectiveness of treatments for depression and anxiety. The evidence for 
effectiveness of treatment of CYP with depression considers the effectiveness of talking therapies and SSRIs (a 
type of antidepressant), rather than the effectiveness of CYPMHS services overall.  
The current NICE recommendation is for group therapy for mild depression, cognitive behavioural therapy (CBT) 
with the option of fluoxetine (a type of SSRI) for moderate to severe depression, and intensive psychological 
therapy combined with medication for depression unresponsive to treatment/recurrent depression/psychotic 
depression.83  
We have identified three relevant UK studies on therapeutic and SSRI treatments for depression and anxiety: 
Goodyer et al (2016) assessed the cost effectiveness of cognitive behavioural therapy, short-term 
psychoanalytical psychotherapy (STPP), and a brief psychosocial intervention (BPI) in adolescents with unipolar 
major depressive disorder treated in CYPMHS.84  
The Adolescent Depression Antidepressant and Psychotherapy Trial (ADAPT) RCT in the UK reported quality of life 
(QoL) improvements for treatment with SSRIs as well as treatment with both SSRIs and CBT.85  
For anxiety we have identified a study by Creswell et al (2017) that reports a QoL benefit of brief guided parent-
delivered CBT (GPD CPD) and solution-focused brief therapy (SFBT) for childhood anxiety disorders.86  
The estimated quality of life benefits from these studies are: 
 
Quality of life benefit87 
Goodyer et al (depression) - BPI 0.22 
Goodyer et al (depression) - CBT 0.20 
Goodyer et al (depression) - STPP 0.24 
ADAPT trial (depression) - SSRIs 0.28 
ADAPT trial (depression) - CBT plus SSRIs 0.25 
Creswell et al (anxiety) - GPD CBT 0.05 
Creswell et al (anxiety) - SFBT 0.11 
 
 We have used the average improvement in QoL following treatment by the above studies as a proxy for the 
average quality adjusted life year (QALY) gain of a CYPMHS service for anxiety or depression88. We believe there is 
high degree of uncertainty in doing so, for the following reasons: 
• The studies do not include a ‘no treatment’ counterfactual, and assume that adolescents would have 
remained at the baseline QoL forever. They also assume the improvement in health is sustained over 
time. However, it is plausible that some adolescents would have improved (and some deteriorated) in the 
                                            
83 https://www.nice.org.uk/guidance/cg28/chapter/1-Recommendations 
84 Goodyer, et al. (2016). Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention 
in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority 
trial. The Lancet. Available at: http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30378-9/abstract 
85 Goodyer, et al. (2008). A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective 
serotonin reuptake inhibitors. The ADAPT trial. Health Technology Assessment, 12(14), iii-iv, ix-60. Available at: 
https://www.ncbi.nlm.nih.gov/pubmed/18462573 
86 Creswell, et al. (2017). Clinical outcomes and cost-effectiveness of brief guided parent-delivered cognitive behavioural therapy and solution-
focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial. Lancet Psychiatry, 4(7), 529-539. Available at: 
https://www.ncbi.nlm.nih.gov/pubmed/28527657 
87 Quality of life is measured on a scale of 0 to 1, where 0 is equivalent to death and 1 is perfect health. 
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absence of the intervention. We believe it is reasonable to assume that about half of children treated will 
either not see a long-term improvement or their improvement can’t be attributed to the treatment89.  
• Studies have different follow up periods ranging from 26 weeks to 86 weeks.  
We therefore multiply the improvements found by 50%. We estimate the average benefit of CYPMHS treatment 
for anxiety or depression as around a 0.1 (10%90) increase in quality of life. 
Wider societal benefits 
Based on the methodology above, Dartington’s Social Research Unit has therefore estimated the wider societal 
benefit of 1:1 sessions of CBT for depression or trauma, as well as individual multimodal therapy for children with 
disruptive behaviour. These benefits are per participant in each intervention. If we assume that the average 
CYPMHS treatment consists of 1:1 CBT, we can apply the wider societal benefits shown below.  
 Depression (£) Trauma (£) Multimodal 
therapy (£) 
NHS savings  5,900 9,000 400 
Earnings 3,200 3,400 600 
 
Break-even analysis for reduction in waiting time for CYPMHS 
We have calculated the necessary minimum reduction in average waiting time required for the benefits of the 
waiting time pilots to outweigh their costs. We have only included one aspect of the benefits of this policy in this 
calculation, and thus our estimate of the number of weeks will be an over-estimate. The aspect of benefits we 
include is the increased amount of time spent with post-treatment quality of life.  
We assume that the average increase in quality of life following treatment in CYPMHS is 0.1 as calculated above. 
Therefore, receiving treatment one year earlier would be equivalent to a gain of 0.1 QALYs. Monetising at 
£60,000 per QALY, this year would be valued at £6,000, while each week in this year would be valued at around 
£115. 
Solely for the purpose of this analysis, we assume a linear rollout profile corresponding to 10% of patients 
experiencing a waiting time standard by 2020/21. We assume that the number of patients treated in CYPMHS 
rises by 10% p.a. from 2018/19 to 2021/22.  
Given the costs of the waiting times pilots from 18/19-20/21, we conclude that a reduction in waiting time of at 
least 6 weeks per child treated in an area with the waiting time standard would result in a positive net present 
value. That is a reduction from current 12 week average wait to a 6 week average wait. 
                                                                                                                                                         
88 We have used a linear extrapolation, based on the QoL and QALY gain of the Goodyer study, to estimate the QALY gain from the reported 
QoL gains in the other studies. 
89 Based on conversations with clinical experts: Professor Miranda Wolpert, Professor Stephen Pilling, Professor Tim Kendall, and Professor 
Peter Fonagy. 
90 10% as compared to full health not baseline health of the individual. i.e. if 1 is full health, a 0.1 increase is moving from 50% health to 60% 
health 
